Gastroesophageal Reflux Disease Device Market by 2024 to 2034: Innovations in Diagnostic Devices
The global gastroesophageal reflux disease (GERD) device market is positioned for substantial growth over the next decade, with a projected market size of USD 1,207.3 million in 2024. According to recent market analysis, this growth is expected to continue at a compound annual growth rate (CAGR) of 3.6%, reaching an estimated market value of USD 1,719.5 million by 2034.
The increasing prevalence of GERD worldwide,
alongside a growing preference for minimally invasive treatments, is fueling
the demand for GERD devices. These innovative devices present a compelling
alternative to traditional medication and surgery, offering patients long-term
relief and improved management of the condition. As GERD becomes more common,
particularly among aging populations, the adoption of these devices is expected
to rise.
Technological advancements in device design are
further driving market expansion. Improved durability, greater efficacy, and
enhanced functionality of GERD devices are making them more attractive to both
patients and healthcare providers. The evolution of these devices is helping to
meet the increasing demand for effective treatment solutions, positioning them
as a viable option in the management of GERD.
However, challenges such as stringent regulatory
approval processes and restrictive reimbursement policies remain. Despite these
obstacles, leading manufacturers in the GERD device sector are actively
exploring strategic partnerships and driving product innovations to navigate
these challenges and accelerate market growth.
With its promising growth prospects, the global
GERD device market presents significant opportunities for both established
industry leaders and emerging players, further strengthening the healthcare
sector's response to the rising global burden of GERD.
Regional Outlook:
- The rise
in the incidence of GERD in Asia Pacific stimulates demand for GERD
devices, with lifestyle changes and food habits contributing to the
increase.
- In Europe,
digital health technology in GERD care is gaining traction, allowing for
remote monitoring and increasing patient engagement in their treatment
path.
- High
healthcare spending and a well-established healthcare system in North
America promote rapid developments in GERD device technology, emphasizing
improving patient outcomes.
“Due to the increasing global prevalence of GERD,
the gastroesophageal reflux disease (GERD) device market is expected to rise.
Market expansion of GERD device is anticipated to be propelled by advancements
in minimally invasive technologies and increasing demand for non-pharmacological
treatment choices.”- opines Sabyasachi
Ghosh Associate Vice President at Future Market Insights
(FMI).
Enhanced Market Demand: Discover Thorough Trends and
Insights in Our Complete Report! https://finance.yahoo.com/news/global-gastroesophageal-reflux-disease-gerd-114000520.html
Key Takeaways:
- In the product
category, the esophagoscopes and gastroscopes segment to acquire a market
share of 90% in 2024.
- The diagnostic
procedures segment in the procedure category to grab a share of 68% in
2024.
- From 2024
to 2034, the India gastroesophageal reflux disease (GERD) device industry
is projected to strengthen at a 5.2% CAGR.
- Thailand gastroesophageal
reflux disease (GERD) device sales are expected to surge at a CAGR of 5.0%
through 2034.
- Through
2034, the Indonesia GERD device market is expected to expand at a CAGR of
3.4%.
- Between
2024 and 2034, the Malaysia gastroesophageal reflux disease (GERD) device
industry is projected to evolve at a CAGR of 4.6%.
- Through
2034, the United States gastroesophageal reflux disease (GERD) device market
is expected to expand at a CAGR of 2.6%.
- Sales of
gastroesophageal reflux disease (GERD) device in Canada are forecast to
rise at a CAGR of 2.9% until 2034.
- The Spain GERD
device market is expected to evolve at a CAGR of 2.9% between 2024 and
2034.
- The France
gastroesophageal reflux disease (GERD) device market anticipates flourishing
at a CAGR of 2.3% between 2024 and 2034.
- The
Germany GERD device market is projected to exhibit growth between 2024 and
2034 at a CAGR of 1.9%.
- Sales of gastroesophageal
reflux disease (GERD) device in Italy are expected to rise at a CAGR of 2.0%
until 2034.
- The United
Kingdom gastroesophageal reflux disease (GERD) device industry is expected
to experience expansion at a CAGR of 1.6% through 2034.
Competitive Landscape:
Prominent gastroesophageal reflux
disease (GERD) device providers continue strategically concentrating on joint
ventures and the distribution expansion of diverse products. To improve the
treatment of diseases, leading gastroesophageal reflux disease (GERD) device
vendors for the condition focus on technological innovation.
Latest Developments:
- China
approved Peptest, a non-invasive radiofrequency device developed by RD
Biomed to diagnose reflux devices. The gadget aids in the general
management of reflux-related gadgets and finds pepsin in saliva samples.
- The
EsophyX Z gastroesophageal reflux disease device, used to conduct
transoral incisionless fundoplication, is an upgraded and newer model of
the EsophyX device.
Prominent
Gastroesophageal Reflux Disease (GERD) Device Vendors:
- Olympus
Corporation
- Pentax
Medical
- KARL STORZ
SE and Co KG.
- Medtronic
Plc
- Fujifilm
Holdings Corporation
- EndoGastric
Solutions
- Medigus
Ltd.
- Diversatek
Inc.
Key
Segments:
By
Product:
- Diagnostic
Devices
- Manometry
Systems
- PH
Monitoring Systems
- Esophagoscopes
and Gastroscopes
- Treatment
Devices
- Ultrasonic
Surgical Endostaplers
- Fundoplication
Devices
- Sphincter
Augmentation Devices
- Radiofrequency
Ablation Devices
By
Procedure:
- Diagnostic
Procedures
- Fundoplication
Procedures
- Radiofrequency
Thermal Ablation
- Magnetic
Sphincter Augmentation
By
End User:
- Hospitals
- Diagnostic
Centers
- Ambulatory
Surgical Centers
By
Region:
- North
America
- Latin
America
- Europe
- East Asia
- South Asia
and Pacific
- Middle
East and Africa (MEA)
About Future Market
Insights (FMI)
Future
Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a
member of the Greater New York Chamber of Commerce) offers profound insights
into the driving factors that are boosting demand in the market. FMI stands as
the leading global provider of market intelligence, advisory services,
consulting, and events for the Packaging, Food and Beverage, Consumer
Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of
over 400 analysts worldwide, FMI provides global, regional, and local expertise
on diverse domains and industry trends across more than 110 countries.
Contact
Us:
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Comments
Post a Comment